GERARDO MOREIRA: Open Payments
NPI 1013935675 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 23 payments from 7 companies in 2025. Trend: 2023 $1,022 · 2024 $669 · 2025 $548
Food & beverage: $437Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $172 |
| Teva Pharmaceuticals USA, Inc. | 6 | $167 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, COBENFY, UZEDY, INGREZZA, ARISTADA, VRAYLAR, Auvelity, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
